The National Barrel Horse Association (NBHA) in conjunction with Luitpold Pharmaceuticals, Inc., makers of Adequan® I.M. (polysulfated glycosaminoglycan) announces “The Adequan® 2D Challenge” to take place at the 2018 NBHA World Championships in Perry, Georgia, October 29 – November 3, 2018.
As part of the newly formed sponsorship with Adequan®, $20,000 will be provided in added money as a “bonus” to the 1D and 2D Open World Champions at this year’s NBHA World Championships. This incentive will be distributed evenly ($10,000 to each champion), which increases the already lucrative $40,000 added money.
“It is an honor to have Luitpold as a new national partner of the NBHA and for them to provide this incentive to our world champions,” says NBHA Manager of Marketing Relations, Len Carter. “Luitpold is making an exceptional investment in our World Championships in addition to the sport of barrel racing and we welcome them to our national partner team.”
“Barrel horses experience wear and tear on their joints, which can influence performance and significantly impact their careers,” says Allyn Mann, Director of Strategic Partnerships at Luitpold Animal Health. “For 30 years, Adequan® i.m. has been used by leading veterinarians, top trainers and riders because of its ability to help improve joint function by reversing the disease cycle, repairing cartilage, restoring joint lubrication and reducing inflammation. ,
“This partnership is a natural extension of our commitment to joint health in the horse and we are excited to be involved with the NBHA – the leading barrel racing association in the world,” adds Mann. “We’d like to wish all the competitors at the 2018 Open World Championships good luck and continued success.” Adequan® i.m. is the only FDA approved equine polysulfated glycosaminoglycan (PSGAG), prescribed for the intramuscular treatment of non-infectious degenerative joint disease (DJD) of the carpal and hock joints in horses. For more information, visit adequan.com. Please see below for Important Safety Information on Adequan.
The NBHA based out of Augusta, Georgia is the largest barrel racing association in the world with over 20,000 members worldwide. The NBHA revolutionized barrel racing by introducing the divisional format and produces over 14 premier shows each year to include two world championships. The association also sanctions over 3,000 state/district shows per year for its members.
The NBHA World championships for the Open and Senior divisions are held each year in Perry, Georgia during October and awards over $300,000 in cash and prizes.
The deadline for 2018 show entries is September 28, 2018.
IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Please see Full Prescribing Information at www.adequan.com.
About Luitpold Animal Health
Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan®. The company’s portfolio is anchored by the only FDA-approved equine polysulfated glycosaminoglycan, which has been relied on for nearly three decades by equine practitioners. As the manufacturer of Adequan® Canine (polysulfated glycosaminoglycan), the company recently returned marketing and distribution of the product to its portfolio, reflecting its position as a leader in joint health care for horses and dogs. Luitpold Pharmaceuticals, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing healthcare marketplace with a growing and diversified portfolio. For more information on Luitpold Animal Health, visit luitpoldanimalhealth.com or call 800- 458-0163.